ストックスクリーナーアプリを入手
14.84
1.02%
0.15
アフターアワーズ：
14.84
前日終値:
$14.69
開ける：
$14.73
24時間の取引高:
1.11M
Relative Volume:
0.64
時価総額：
$1.56B
収益：
-
当期純損益:
$-115.88M
株価収益率:
-9.594
EPS:
-1.5468
ネットキャッシュフロー:
$-104.72M
1週間 パフォーマンス:
+3.60%
1か月 パフォーマンス:
-12.24%
6か月 パフォーマンス:
-53.57%
1年 パフォーマンス:
-14.76%
1日の値動き範囲:
$14.39
$15.05
1週間の範囲:
$13.80
$15.05
52週間の値動き範囲:
$10.60
$38.12
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
EWTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
14.84 | 1.51B | 0 | -115.88M | -104.72M | -1.5468 |
|
ONC
Beone Medicines Ltd Adr
|
251.72 | 25.78B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
446.48 | 114.53B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.3401 | 40.54M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
84.81 | 6.44B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
487.86 | 65.13B | 14.09B | 4.50B | 2.96B | 39.28 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-30 | 開始されました | Guggenheim | Buy |
| 2025-04-02 | ダウングレード | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | 開始されました | Scotiabank | Sector Outperform |
| 2025-01-22 | 開始されました | Stifel | Hold |
| 2024-11-22 | 開始されました | Evercore ISI | Outperform |
| 2024-03-07 | 開始されました | Piper Sandler | Overweight |
| 2023-05-01 | 開始されました | Truist | Buy |
| 2022-08-25 | ダウングレード | Goldman | Neutral → Sell |
| 2022-04-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-01-28 | 開始されました | Goldman | Neutral |
すべてを表示
Edgewise Therapeutics Inc (EWTX) 最新ニュース
Muscle Disease Leader Edgewise Therapeutics Set for Key Goldman Sachs Healthcare Conference Presentation - Stock Titan
Universal Beteiligungs und Servicegesellschaft mbH Invests $2.40 Million in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Two Sigma Investments LP Has $3.52 Million Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Certain Stock Options of Edgewise Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 2-JUN-2025. - marketscreener.com
Certain Common Stock of Edgewise Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 2-JUN-2025. - marketscreener.com
(EWTX) Technical Data - news.stocktradersdaily.com
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Purchased by Nuveen Asset Management LLC - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by Polar Asset Management Partners Inc. - MarketBeat
Edgewise Therapeutics: Upcoming DMD Trial Data May Disappoint (NASDAQ:EWTX) - Seeking Alpha
Nuveen Asset Management LLC Acquires 158,452 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World
Woodline Partners LP Has $15.15 Million Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 174% Potential Upside in Biotech - DirectorsTalk Interviews
BNP Paribas Financial Markets Makes New $883,000 Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
106,562 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Purchased by Point72 Asset Management L.P. - MarketBeat
Frazier Life Sciences Management L.P. Cuts Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics’ SWOT analysis: promising rare disease pipeline faces challenges By Investing.com - Investing.com South Africa
Edgewise Therapeutics’ SWOT analysis: promising rare disease pipeline faces challenges - Investing.com India
Soleus Capital Management L.P. Acquires New Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Polar Asset Management Partners Inc. Trims Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Tang Capital Management LLC Takes Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Deutsche Bank AG Grows Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
How to Take Advantage of moves in (EWTX) - news.stocktradersdaily.com
Northern Trust Corp Acquires 35,426 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Brokerages Set Edgewise Therapeutics, Inc. (NASDAQ:EWTX) PT at $40.22 - MarketBeat
Balyasny Asset Management L.P. Buys Shares of 23,364 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
All You Need to Know About Edgewise Therapeutics (EWTX) Rating Upgrade to Buy - MSN
Ensign Peak Advisors Inc Acquires New Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 20, 2025 - PR Newswire
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) is MPM Bioimpact LLC's 3rd Largest Position - MarketBeat
Paradigm Biocapital Advisors LP Grows Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Parkman Healthcare Partners LLC Sells 275,897 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Janus Henderson Group PLC Purchases 425,421 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
D. E. Shaw & Co. Inc. Purchases 231,023 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
J. Goldman & Co LP Increases Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Research Analysts Offer Predictions for EWTX FY2029 Earnings - MarketBeat
Granahan Investment Management LLC Sells 211,892 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Northern Trust Corp Boosts Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World
Cubist Systematic Strategies LLC Makes New $5.86 Million Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Does Edgewise Therapeutics (EWTX) Have the Potential to Rally 174.68% as Wall Street Analysts Expect? - Yahoo Finance
Edgewise Therapeutics Inc (EWTX) 財務データ
収益
当期純利益
現金流量
EPS
0.87%
0.19%
大文字化:
|
ボリューム (24 時間):